These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7619721)

  • 61. Malignant rhabdoid tumor of the brain and kidney in a child: clinical and pathologic features.
    Cohn RD; Frank Y; Stanek AE; Kalina P
    Pediatr Neurol; 1995 Jul; 13(1):65-8. PubMed ID: 7575853
    [TBL] [Abstract][Full Text] [Related]  

  • 62. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Directed mutagenesis reveals that two histidines in tissue inhibitor of metalloproteinase-1 are each essential for the suppression of cell migration, invasion, and tumorigenicity.
    Walther SE; Denhardt DT
    Cell Growth Differ; 1996 Nov; 7(11):1579-88. PubMed ID: 8930408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
    Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
    BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues].
    Takino T; Sato H; Seiki M
    Nihon Rinsho; 1995 Jul; 53(7):1791-7. PubMed ID: 7630021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Narrowing the critical region for a rhabdoid tumor locus in 22q11.
    Biegel JA; Allen CS; Kawasaki K; Shimizu N; Budarf ML; Bell CJ
    Genes Chromosomes Cancer; 1996 Jun; 16(2):94-105. PubMed ID: 8818656
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation.
    Pimentel J; Silva R; Pimentel T
    J Neurooncol; 2003 Jan; 61(2):121-6. PubMed ID: 12622450
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Malignant rhabdoid tumor of the brain: quantitative 1H MR-spectroscopy and cytogenetics.
    Huisman TA; Brandner S; Niggli F; Betts DR; Boltshauser E; Martin E
    Neuropediatrics; 2000 Jun; 31(3):159-61. PubMed ID: 10963106
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system.
    Hasserjian RP; Folkerth RD; Scott RM; Schofield DE
    J Neurooncol; 1995; 25(3):193-203. PubMed ID: 8592169
    [No Abstract]   [Full Text] [Related]  

  • 70. Chromosome analyses in a rhabdoid tumor of the brain.
    Klopfenstein K; Soukup S; Blough R; Mazewski C; Ballard E; Gotwals B; Lampkin B
    Cancer Genet Cytogenet; 1997 Feb; 93(2):152-6. PubMed ID: 9078300
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel Two MRT Cell Lines Established from Multiple Sites of a Synchronous MRT Patient.
    Kuwahara Y; Iehara T; Ichise E; Katsumi Y; Ouchi K; Tsuchiya K; Miyachi M; Konishi E; Sasajima H; Nakamura S; Fumino S; Tajiri T; Johann PD; FrÜhwald MC; Yoshida T; Okuda T; Hosoi H
    Anticancer Res; 2020 Nov; 40(11):6159-6170. PubMed ID: 33109553
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful treatment of disseminated central nervous system malignant rhabdoid tumor.
    Olson TA; Bayar E; Kosnik E; Hamoudi AB; Klopfenstein KJ; Pieters RS; Ruymann FB
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):71-5. PubMed ID: 7743242
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Isolated Pure Malignant Rhabdoid Tumor (MRT) of the Bladder: Case Report and Lessons Learned.
    Hecht SL; Walker JP; Treece AL; Cost NG
    Urology; 2020 Mar; 137():164-167. PubMed ID: 31733273
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary malignant rhabdoid tumor of the central nervous system: case report and review of the literature.
    Satoh H; Goishi J; Sogabe T; Uozumi T; Kiya K; Migita K
    Surg Neurol; 1993 Nov; 40(5):429-34. PubMed ID: 8211663
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pineal malignant rhabdoid tumor with chondroid formation in an adult.
    Sugita Y; Takahashi Y; Hayashi I; Morimatsu M; Okamoto K; Shigemori M
    Pathol Int; 1999 Dec; 49(12):1114-8. PubMed ID: 10632935
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Malignant Rhabdoid Tumor of Soft Tissue.
    Guilmette J; Laverdière C; Soulières D; Patey N; Soucy G; Trudel D; Bouron-Dal Soglio D
    Pediatr Dev Pathol; 2017 Jun; 20(3):262-266. PubMed ID: 28429647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Congenital extrarenal non-central nervous system malignant rhabdoid tumor.
    Sajedi M; Wolff JE; Egeler RM; Pinto A; Hughes R; Anderson RA; Coppes MJ
    J Pediatr Hematol Oncol; 2002 May; 24(4):316-20. PubMed ID: 11972104
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours.
    Custers L; Khabirova E; Coorens THH; Oliver TRW; Calandrini C; Young MD; Vieira Braga FA; Ellis P; Mamanova L; Segers H; Maat A; Kool M; Hoving EW; van den Heuvel-Eibrink MM; Nicholson J; Straathof K; Hook L; de Krijger RR; Trayers C; Allinson K; Behjati S; Drost J
    Nat Commun; 2021 Mar; 12(1):1407. PubMed ID: 33658498
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of primary malignant rhabdoid tumor of the brain: report of three cases and review of the literature.
    Weiss E; Behring B; Behnke J; Christen HJ; Pekrun A; Hess CF
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1013-9. PubMed ID: 9719110
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification.
    Kees UR; Spagnolo D; Hallam LA; Ford J; Ranford PR; Baker DL; Callen DF; Biegel JA
    Cancer Genet Cytogenet; 1998 Jan; 100(2):159-64. PubMed ID: 9428362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.